Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability
Gustavo Henrique Oliveira-Paula Fernanda Borchers Coeli-Lacchini; Letícia Perticarrara Ferezin; Graziele Cristina Ferreira; Lucas Cezar Pinheiro; Waynice Neiva de Paula Garcia; Luis Vicente Garcia; José Eduardo Tanus-Santos; Riccardo Lacchini
European Journal of Clinical Pharmacology Heidelberg v. 77, n. 6, p. 869-877, 2021
Heidelberg 2021
Localização:
EERP - Esc. Enfermagem Ribeirão Preto
(pcd 3048993 Acervo Digital )(Acessar)
Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production
Gustavo Henrique Oliveira-Paula Lucas C Pinheiro; Graziele C Ferreira; Waynice Neiva de Paula Garcia; Riccardo Lacchini; Luis Vicente Garcia; José Eduardo Tanus-Santos
Free Radical Biology and Medicine New York v. 115, p. 10-17, 2018
Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol
Gustavo Henrique Oliveira-Paula Riccardo Lacchini; Lucas Cezar Pinheiro; Graziele Cristina Ferreira; Marcelo Rizzatti Luizon; Waynice Neiva de Paula Garcia; Luis Vicente Garcia; José Eduardo Tanus-Santos